H1B Report
Side-by-side comparison

COGNIZANT TECHNOLOGY SOLUTIONS US CORP vs Genpact LLC

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
TXRank #2FEIN 13-3924155
Entity B
Genpact LLC
NJRank #185FEIN 22-3658826

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricCOGNIZANT TECHNOLOGY SOLUTIONS US CORPGenpact LLC
Total filings128,8522,808
Certified %96.13%97.58%
Denied %0.28%0.39%
Withdrawn %2.23%0.28%
Cert-withdrawn %1.36%1.75%
Rank#2#185
Active yearsFY2010–FY2026FY2011–FY2026
Worksite stateTXNJ

Outcomes — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Cert-withdrawn 1.4%, Withdrawn 2.2%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%

Outcomes — Genpact LLC

DOL case-status mix.

Outcome breakdown: Certified 97.6%, Cert-withdrawn 1.8%, Withdrawn 0.3%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified97.6%
Cert-withdrawn1.8%
Withdrawn0.3%
Denied0.4%
Certified97.6%
Cert-withdrawn1.8%
Withdrawn0.3%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

COGNIZANT TECHNOLOGY SOLUTIONS US CORP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,476
FY20112,735
FY20121,772
FY20131,557
FY20142,189
FY20153,112
FY20164,612
FY20172,384
FY201812,460
FY201925,569
FY20203,117
FY202110,079
FY202213,705
FY202315,729
FY202411,437
FY202511,140
FY20265,779
Genpact LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY201125
FY201297
FY201383
FY2014228
FY2015292
FY2016308
FY2017420
FY2018271
FY2019387
FY20200
FY20210
FY20220
FY202348
FY2024260
FY2025226
FY2026163

Top 5 occupations — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.